The immunoblotting was performed as described previously [68 (link)]. The following antibodies were used: anti-LRRC7 (PA5-70660; Thermo Fisher Scientific), anti-SHANK2 (#12218; Cell Signaling Technology, Beverly, MA, USA), anti-GRIN2B (06-600; Merck Millipore, Burlington, MA, USA), anti-SynGAP (#3200; Cell Signaling Technology), anti-Alpha-Synuclein (610787; BD Biosciences, Franklin Lakes, NJ, USA), anti-RAB4A (ab13252; Abcam), anti-GGT7 (ab80903, Abcam) and anti-MTCO1 (ab45918, Abcam).
Free full text: Click here